UROGESIC BLUE (EDWARDS PHARMACEUTICAL, INC.)
Welcome to the PulseAid listing for the UROGESIC BLUE drug offered from EDWARDS PHARMACEUTICAL, INC.. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | EDWARDS PHARMACEUTICAL, INC. |
| NON-PROPRIETARY NAME: | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, and HYOSCYAMINE SULFATE |
| SUBSTANCE NAME: | METHENAMINE; SODIUM PHOSPHATE, MONOBASIC; METHYLENE BLUE; HYOSCYAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2010-04-30 |
| END MARKETING DATE: | 0000-00-00 |
UROGESIC BLUE HUMAN PRESCRIPTION DRUG Details:
| Item Description | UROGESIC BLUE from EDWARDS PHARMACEUTICAL, INC. |
| LABELER NAME: | EDWARDS PHARMACEUTICAL, INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 81.6; 40.8; 10.8; .12(mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2010-04-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0485-0051_9431983a-58df-4d8c-91f5-6843811c4537 |
| PRODUCT NDC: | 0485-0051 |
| APPLICATION NUMBER: | |
Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
